Takeda snaps up GammaDelta Therapeutics
GammaDelta is focused on research into gamma delta T cells for potential use in immunotherapy, primarily addressing solid tumours
Read More
Author: Lucy Parsons
Novartis UK awarded Innovation Passport for investigational therapy
Iptacopan is an investigational, first-in-class, orally administered factor B inhibitor for the alternative pathway of the complement system
Read More
Clinical Researcher of the Year – The Americas 2021 winners announced
The winners of the 2021 Clinical Researcher of the Year – The Americas have been announced, find out who emerged victorious
Read More
Double vaccinated can still spread COVID-19 at home, says UK study
Experts say that it is vital to ensure that every member who is eligible for a vaccine has received one
Read More
EMA nod for excessive daytime sleepiness med Ozawade
Med approved for the treatment of excessive daytime sleepiness associated with obstructive sleep apnoea in adults
Read More- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
- BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development
- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
